e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Experimental approaches to the study of chronic cough and cigarette smoking
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of laryngopharyngeal reflux and acid aspiration using exhaled breath condensate pH
S. Hom, A. Smith, D. Bunyan, Y. Yu, J. F. Hunt (Charlottesville, United States Of America)
Source:
Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Session:
Experimental approaches to the study of chronic cough and cigarette smoking
Session type:
Oral Presentation
Number:
3156
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hom, A. Smith, D. Bunyan, Y. Yu, J. F. Hunt (Charlottesville, United States Of America). Identification of laryngopharyngeal reflux and acid aspiration using exhaled breath condensate pH. Eur Respir J 2005; 26: Suppl. 49, 3156
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Assessment of exhaled breath condensate for non-invasive diagnosis of gastroesophageal reflux disease
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
Iron concentrations in exhaled breath condensate of children with asthma and gastroesophageal reflux disease
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Reproducibility of exhaled breath condensate pH in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004
Exhaled breath condensate pH is a robust and reproducible assay of airway acidity
Source: Eur Respir J 2003 Dec 01;22(6):889-894
Year: 2003
Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007
Detection of pepsin in sputum and exhaled breath condensate: could it be a useful marker for reflux-related respiratory disease?
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009
Conductivity and pH in exhaled breath condensate of stable asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 789s
Year: 2006
Electrical conductivity, pH and ammonia in exhaled breath condensate (EBC) from patients with different airway disorders
Source: Eur Respir J 2006; 28: Suppl. 50, 790s
Year: 2006
Exhaled breath condensate pH for the identification of asymptomatic children at risk of asthma
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
pH in exhaled breath condensate of patients with inflammatory airway diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 240s
Year: 2003
Exhaled breath condensate pH
Source: Eur Respir Monogr 2010; 49: 173-182
Year: 2010
Continuous exhaled breath condensate pH monitoring
Source: Eur Respir J 2004; 24: Suppl. 48, 27s
Year: 2004
Utility of exhaled breath condensate pH as a biomarker in COPD remains undefined
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
The effect of gas standardisation on exhaled breath condensate pH
Source: Eur Respir J 2006; 28: 251-252
Year: 2006
pH in exhaled breath condensate of patients with stable and unstable asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 508s
Year: 2004
Exhaled breath condensate pH
Source: Eur Respir J 2004; 23: 961-962
Year: 2004
Rapid pH-measurement in exhaled breath condensate with an innovative pH-IsFET
Source: Eur Respir J 2006; 28: Suppl. 50, 789s
Year: 2006
Keratin detected in exhaled breath condensate is an environmental contaminant
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005
Exhaled breath condensate pH and peak flow variability in asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
The effect of gas standardisation on exhaled breath condensate pH and PCO2
Source: Eur Respir J 2007; 30: 185-187
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept